Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Future Avenues for Prediabetes Treatment: The R...

Prediabetes is a significant health concern characterized by elevated blood sugar levels that fall between the normal range and the diagnostic threshold for type 2 diabetes. Often labeled as border...

Dec 25, 2023

Opioid-Induced Respiratory Depression Market Outlook
Opioid-Induced Respiratory Depression: Unveiling the Silent Threat

In recent years, the misuse and abuse of opioids have become a growing concern worldwide, with devastating consequences for public health. While the immediate dangers of opioid overdose are well-documented, a silent and potentially lethal complication often lurks in the shadows—opioid-induced respiratory depression...

Find More
Artificial Tears Market Analysis
Exploring the Growing Demand and Evolving Market Dynamics of Artificial Tears

The landscape of technology has indelibly reshaped various industries, and the healthcare sector stands as a prime beneficiary, especially evident in the profound innovation and intense development seen in the Artificial Tears Market in recent years. The advancements in nanotechnology, biotechnology, and material s...

Find More
expanding-market-of-complement-inhibitor
The Expanding Market of Complement Inhibitors

The development of complement inhibitors has been growing rapidly over the years, and it has proved to be one of the breakthroughs in various therapeutic areas. These inhibitors act on the dysregulated complement system, a group of proteins that forms an essential part of innate immunity. This system comes into eff...

Find More

More Views & Analysis

lyfgenia-or-casgevy-for-sickle-cell-disease-treatment
Lyfgenia or Casgevy: Who Will Lead the Sickle Cell Disease Treatment Space?

History has been created as the world captures the significance of the FDA’s approval of Casgevy (exa-cel), a collaboration between Vertex Pharmaceuticals and CRISPR Therapeutics, for the treatment of sickle cell disease (SCD). This groundbreaking therapy represents a long-awaited potential cure for the debilitatin...

Find More

Cardiac Rhythm Management Devices Market Analysis
Understanding the Growth and the Evolving Market Dynamics of Cardiac Rhythm Management Devices

Globally, cardiovascular diseases (CVDs) stand as the primary cause of mortality, claiming an estimated 17.9 million lives in 2019 alone, which accounted for 32% of all global deaths. Among these fatalities, a staggering 85% were attributed to heart attacks and strokes. Within the spectrum of noncommunicable diseas...

Find More

jaypirca-for-chronic-lymphocytic-leukemia
Eli’s Jaypirca: A Beacon of Success in the BTK Inhibitor Market

As the battle intensifies among AbbVie, Johnson & Johnson, AstraZeneca, and BeiGene in the BTK inhibitor market, Eli Lilly stands out by forging a new direction in the landscape of blood cancer drugs. Just at the beginning of this month, the FDA granted accelerated approval to Lilly’s Jaypirca. This approval is...

Find More

unlocking-the-future-of-hematology-ash-2023-preview
Unlocking the Future of Hematology: A Sneak Peek into ASH 2023 Discoveries!

The upcoming 65th American Society of Hematology (ASH) Annual Meeting and Exposition 2023 is just around the corner, and leading pharmaceutical giants like BMS, Genmab, AstraZeneca, Regeneron, BeiGene, ADC Therapeutics, Eli Lilly and Company, Janssen, and others are gearing up for this conference. This conference w...

Find More

ixchiq-first-ever-chikungunya-vaccine
Valneva’s Ixchiq: First-Ever Chikungunya Vaccine

Over the past 15 years, an estimated 5 million cases of chikungunya have surfaced globally. This virus poses an escalating menace, having affected over half of the world’s nations. Recent cases in Spain, Italy, and France underscore its widespread reach. Additionally, the virus has expanded to new geographical area...

Find More

Implantable Drug Delivery Devices Market Outlook
Assessing the Emerging Trends in the Evolving Implantable Drug Delivery Device Landscape

The Implantable Drug Delivery Device market has experienced a monumental surge driven by an amalgamation of technological innovation, burgeoning demand, and the strategic maneuvers of key industry players. According to DelveInsight's latest assessment, the global Implantable Drug Delivery Device Market is poised to...

Find More

RNAi is a fundamental gene-silencing pathway in eukaryotic cells, where long pieces of double-strand.....

Find More

Healthcare Performance Improvement provides proven methods for sustaining and building a culture of .....

Find More

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare form of neoplasm, generally .....

Find More

Medical device manufacturing and development is a high-capital demanding endeavor and therefore the .....

Find More

Raynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused b.....

Find More

Soft Tissue Sarcoma (STS) tumors constitute 1% of all the malignancies. These are rare neoplasms tha.....

Find More